Folic Acid and Vitamin B12 Administration in CKD, Why Not?

Patients affected by chronic kidney disease (CKD) or end-stage renal disease (ESRD) experience a huge cardiovascular risk and cardiovascular events represent the leading causes of death. Since traditional risk factors cannot fully explain such increased cardiovascular risk, interest in non-tradition...

Descripción completa

Detalles Bibliográficos
Autores principales: Capelli, Irene, Cianciolo, Giuseppe, Gasperoni, Lorenzo, Zappulo, Fulvia, Tondolo, Francesco, Cappuccilli, Maria, La Manna, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413093/
https://www.ncbi.nlm.nih.gov/pubmed/30781775
http://dx.doi.org/10.3390/nu11020383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413093/
https://www.ncbi.nlm.nih.gov/pubmed/30781775
http://dx.doi.org/10.3390/nu11020383

Ejemplares similares